---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-170634"
form_type: "8-K"
ticker: "MDGL"
cik: "0001157601"
company_name: "MADRIGAL PHARMACEUTICALS, INC."
filed_at: "2024-06-27T23:59:59+00:00"
generated_at: "2026-06-01T00:56:43.743137+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Madrigal shareholders approve 750K share increase to stock plan, extend to 2035

## Summary
- Stockholders approved amendment to 2015 Stock Plan, increasing share reserve by 750,000 shares.
- Plan extended through 2035; clawback policy and one-year minimum vesting requirement added.
- All three Class II director nominees (Sibold, Taub, Craves) elected with over 95% support.
- PricewaterhouseCoopers ratified as independent auditor for FY2024 with 99.4% of votes cast.

## SEC filing metadata
- accession: 0001193125-24-170634
- form_type: 8-K
- ticker: MDGL
- cik: 0001157601
- company_name: MADRIGAL PHARMACEUTICALS, INC.
- filed_at: 2024-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157601/000119312524170634/0001193125-24-170634-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157601/000119312524170634/d839852d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-170634
- JSON: https://secwatch.observer/filing/0001193125-24-170634.json
- Plain text: https://secwatch.observer/filing/0001193125-24-170634.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.